Literature DB >> 28280928

Urothelial carcinoma in first histological diagnosis of patients over 80 years has distinctive histological features: a retrospective single-institution study of 185 patients.

Adeline Furudoï1,2, Justine Varinot3,4, Véronique Phe3,5, Morgan Roupret3,5, Marc-Olivier Bitker3,5, Eva Compérat3,4.   

Abstract

Few histological data are known about patients with a first diagnosis of bladder cancer (BC) at the age ≥80 years. We describe the largest series in this patient group and their distinctive histological features. This unicentric retrospective study included patients at the age ≥80 years with a first diagnosis of bladder cancer between 2005 and 2015. All diagnosis was made by one senior uropathologist according to the WHO 2016 classification, pTNM 7th edition 2009. We examined samples of 185 patients, sex ratio M:W = 2.49:1, with ≥80 years at the time of first diagnosis of BC. The mean age was 85.1 years (84.8 for men and 85.8 for women). One hundred sixteen patients were diagnosed with NMIBC (non-muscle invasive bladder cancer) (62.7%). Sixty-nine patients were detected with MIBC (muscle invasive bladder cancer) (37.3%). In the MIBC, 20 (29.0%) cases, a divergent differentiation was reported. No patient had primary carcinoma in situ (Cis) at time of diagnosis, and concomitant Cis was observed in 18.9% (35 cases). According to our results, the histopathological findings are different from those of other patients' groups. The study shows a higher number of MIBC and a high percentage of histological variants. We could show distinctive pathological features in this patient group.

Entities:  

Keywords:  Bladder cancer; Elderly; Micropapillary carcinoma; Nested carcinoma; Plasmacytoid carcinoma

Mesh:

Year:  2017        PMID: 28280928     DOI: 10.1007/s00428-017-2099-x

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  23 in total

1.  Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification.

Authors:  Samson W Fine; Peter A Humphrey; Louis P Dehner; Mahul B Amin; Jonathan I Epstein
Journal:  J Urol       Date:  2005-11       Impact factor: 7.450

2.  Comparison of complications from radical cystectomy between old-old versus oldest-old patients.

Authors:  Evi Comploj; Jeremy West; Michael Mian; Luis Alex Kluth; Alexander Karl; Christopher Dechet; Shahrokh F Shariat; Christian G Stief; Emanuela Trenti; Salvatore Palermo; Michele Lodde; Wolfgang Horninger; Stephan Madersbacher; Armin Pycha
Journal:  Urol Int       Date:  2014-06-24       Impact factor: 2.089

3.  Radical cystectomy in patients over 70 years of age: impact of comorbidity on perioperative morbidity and mortality.

Authors:  Vladimir Novotny; Stefan Zastrow; Rainer Koch; Manfred P Wirth
Journal:  World J Urol       Date:  2011-11-02       Impact factor: 4.226

4.  Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old.

Authors:  Eva Compérat; Stéphane Larré; Morgan Roupret; Yann Neuzillet; Géraldine Pignot; Hervé Quintens; Nadine Houéde; Catherine Roy; Xavier Durand; Justine Varinot; Dimitri Vordos; Mathieu Rouanne; Mohammed Adnan Bakhri; Priscilla Bertrand; Stephane Calin Jeglinschi; Olivier Cussenot; Michel Soulié; Christian Pfister
Journal:  Virchows Arch       Date:  2015-02-20       Impact factor: 4.064

5.  Late age (85 years or older) peak incidence of bladder cancer.

Authors:  Matthew Schultzel; Sidney L Saltzstein; Tracy M Downs; Suzuho Shimasaki; Catherine Sanders; Georgia Robins Sadler
Journal:  J Urol       Date:  2008-03-04       Impact factor: 7.450

6.  Different subtypes of carcinoma in situ of the bladder do not have a different prognosis.

Authors:  Eva Compérat; Solene-Florence Jacquet; Justine Varinot; Pierre Conort; Morgan Roupret; Emmanuel Chartier-Kastler; Marc-Olivier Bitker; Johannes Alfred Witjes; Olivier Cussenot
Journal:  Virchows Arch       Date:  2013-02-10       Impact factor: 4.064

7.  Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer.

Authors:  J Alfred Witjes; Thierry Lebret; Eva M Compérat; Nigel C Cowan; Maria De Santis; Harman Maxim Bruins; Virginia Hernández; Estefania Linares Espinós; James Dunn; Mathieu Rouanne; Yann Neuzillet; Erik Veskimäe; Antoine G van der Heijden; Georgios Gakis; Maria J Ribal
Journal:  Eur Urol       Date:  2016-06-30       Impact factor: 20.096

8.  Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients.

Authors:  Ashish M Kamat; Colin P N Dinney; Jason R Gee; H Barton Grossman; Arlene O Siefker-Radtke; Pheroze Tamboli; Michelle A Detry; Tracy L Robinson; Louis L Pisters
Journal:  Cancer       Date:  2007-07-01       Impact factor: 6.860

9.  Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy.

Authors:  Bastian Keck; Sven Wach; Robert Stoehr; Frank Kunath; Simone Bertz; Jan Lehmann; Michael Stöckle; Helge Taubert; Bernd Wullich; Arndt Hartmann
Journal:  BMC Cancer       Date:  2013-02-08       Impact factor: 4.430

Review 10.  Prognostic significance of lymphovascular invasion in radical cystectomy on patients with bladder cancer: a systematic review and meta-analysis.

Authors:  Hwanik Kim; Myong Kim; Cheol Kwak; Hyeon Hoe Kim; Ja Hyeon Ku
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.